Devices › Device types
FDA product code DXE · class 2 · Cardiovascular
Catheter, embolectomy: medical device reports filed with FDA
7,789 reports carry this product code, 1992–2026; 16 brands with a page.
- 7,789
- reports with this product code
- 0% of all MAUDE reports
- 468
- reports, 12 months to August 2026
- 307 in the 12 months before
- 80.1%
- classified as malfunction
- 62.3% across all reports
- 1.8%
- classified as death, as reported
- 0.9% across all reports
Product code DXE is FDA's classification for "Catheter, embolectomy" (cardiovascular panel), a class 2 device. 7,789 medical device reports carry this product code, 0% of the MAUDE database, from January 1992 to August 2026.
468 reports arrived in the 12 months to August 2026, up 52% from 307 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (80.1%), injury (14.4%) and other (3.2%). 16 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Fogarty Arterial Embolectomy Catheter | 1,155 | 37 | 0.2% | 87.4% |
| AngioJet SOLENT omni | 609 | 26 | 1.3% | 93.1% |
| Fogarty Thru-Lumen Embolectomy Catheter | 426 | 76 | 0.7% | 95.8% |
| Indigo System Aspiration Catheter 6 | 396 | 0 | 0% | 97.2% |
| TufTex Over-the-Wire Embolectomy Catheter | 360 | 159 | 0% | 99.7% |
| Angiojet Zelantedvt | 248 | 0 | 5.3% | 76.3% |
| Indigo System Aspiration Catheter 8 | 169 | 2 | 1.5% | 90.8% |
| Indigo System Separator 8 | 122 | 4 | 1.9% | 75.8% |
| Indigo System Catrx Aspiration Catheter | 96 | 11 | 0% | 90.7% |
| AngioJet SOLENT Proxi | 33 | 5 | 4.6% | 84.6% |
| AdvanCE | 31 | 8 | 2.7% | 72.7% |
| Pruitt F3 Carotid Shunt | 23 | 73 | 0.3% | 92.9% |
| Internal Hex Implant | 2 | 0 | 0% | 0% |
| Galileo | 1 | 0 | 0.1% | 97.6% |
| Penumbra System Jet7 Reperfusion Catheter | 1 | 0 | 4% | 81.5% |
| Ruby Coil | 1 | 26 | 0.1% | 95.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Edwards Lifesciences Pr | 1,597 | 20.5% |
| Penumbra | 1,303 | 16.7% |
| Boston Scientific - Maple Grove | 929 | 11.9% |
| Lemaitre Vascular | 826 | 10.6% |
| Arrow International | 376 | 4.8% |
| Edwards Lifesciences | 307 | 3.9% |
| Applied Medical Resources | 199 | 2.6% |
| Arrow Intl | 175 | 2.2% |
| Medos International Sarl | 116 | 1.5% |
| Vascular Solutions | 87 | 1.1% |
| Applied Medical | 55 | 0.7% |
| Boston Scientific | 53 | 0.7% |
| Medtronic | 44 | 0.6% |
| Ev3 | 32 | 0.4% |
| Merit Medical Systems | 15 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 988 | 12.7% |
| Material rupture | 918 | 11.8% |
| Aspiration issue | 501 | 6.4% |
| Material deformation | 471 | 6% |
| Device displays incorrect message | 454 | 5.8% |
| Material separation | 447 | 5.7% |
| Material fragmentation | 441 | 5.7% |
| Detachment of device component | 385 | 4.9% |
| Deflation problem | 307 | 3.9% |
| Detachment of device or device componentpart of the device came off | 298 | 3.8% |
| Kinkedthe tube or line kinked | 245 | 3.1% |
| Physical resistance/sticking | 218 | 2.8% |
| Difficult to removethe device was hard to remove | 202 | 2.6% |
| Leak/splashthe device leaked | 199 | 2.6% |
| Device damaged prior to usethe device was damaged before use | 178 | 2.3% |
| Suction problem | 163 | 2.1% |
| Burst container or vessel | 161 | 2.1% |
| Tip breakage | 155 | 2% |
| Failure to advance | 143 | 1.8% |
| Physical resistance | 143 | 1.8% |
Questions about catheter, embolectomy reports
What is product code DXE?
FDA's classification code for "Catheter, embolectomy", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
7,789 reports through August 2026, 468 of them in the latest 12 months.
Which brands appear most often?
Fogarty Arterial Embolectomy Catheter (1,155), AngioJet SOLENT omni (609), Fogarty Thru-Lumen Embolectomy Catheter (426), Indigo System Aspiration Catheter 6 (396) and TufTex Over-the-Wire Embolectomy Catheter (360). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.